Track topics on Twitter Track topics that are important to you
An inspection at a manufacturing facility belonging to Health Pharma has revealed breaches of cGMP regulations, causing the FDA to send a warning letter.
The post FDA issues warning letter to Health Pharma for cGMP violations appeared first on European Pharmaceutical Review.
Original Article: FDA issues warning letter to Health Pharma for cGMP violationsNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...